The online medical services provider raised about $20 million after pricing its shares at the bottom of their range – below a Nasdaq-proposed new minimum threshold of $25 millionKey Takeaways:PomDoctor priced its IPO shares at the bottom of their range, seeking a high P/S ratio of nearly 10 that values the company at $472 millionThe company was racing to complete its listing before the rollout of new Nasdaq rules that will require all new foreign listings to raise at least $25 millionJust last month we wrot ...

, /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the closing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at a public offering price of US$4.00 per ADS. Six ADSs represent one Class A ordinary share, par value US$0.0001 per share, of the Company. The ADSs began trading on Nasdaq Global Market on October 8, 2025 under the ticker symbol ...